Literature DB >> 25369624

Dyspareunia in women.

Dean A Seehusen1, Drew C Baird2, David V Bode1.   

Abstract

Dyspareunia is recurrent or persistent pain with sexual activity that causes marked distress or interpersonal conflict. It affects approximately 10% to 20% of U.S. women. Dyspareunia can have a significant impact on a woman's mental and physical health, body image, relationships with partners, and efforts to conceive. The patient history should be taken in a nonjudgmental way and progress from a general medical history to a focused sexual history. An educational pelvic examination allows the patient to participate by holding a mirror while the physician explains normal and abnormal findings. This examination can increase the patient's perception of control, improve self-image, and clarify findings and how they relate to discomfort. The history and physical examination are usually sufficient to make a specific diagnosis. Common diagnoses include provoked vulvodynia, inadequate lubrication, postpartum dyspareunia, and vaginal atrophy. Vaginismus may be identified as a contributing factor. Treatment is directed at the underlying cause of dyspareunia. Depending on the diagnosis, pelvic floor physical therapy, lubricants, or surgical intervention may be included in the treatment plan.

Entities:  

Mesh:

Year:  2014        PMID: 25369624

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  7 in total

1.  Successful Treatment of Dyspareunia with an Integrative Medicine Approach: A Case Report.

Authors:  Brenda Arthur; Myung Kyu Chung; Tracy Brobyn; Patrick J LaRiccia
Journal:  Integr Med (Encinitas)       Date:  2019-12

Review 2.  Pharmacotherapy for Sexual Dysfunction in Women.

Authors:  Jeong Hoo Lee; Jenny E Lee; Veronica Harsh; Anita H Clayton
Journal:  Curr Psychiatry Rep       Date:  2022-02-01       Impact factor: 5.285

3.  Patient-Physician Interactions Regarding Dyspareunia with Endometriosis: Online Survey Results.

Authors:  Kathryn Witzeman; Oscar Antunez Flores; Roberta I Renzelli-Cain; Brett Worly; Janelle K Moulder; Jorge F Carrillo; Beth Schneider
Journal:  J Pain Res       Date:  2020-06-29       Impact factor: 3.133

4.  High rate of dyspareunia and probable vulvodynia in Ehlers-Danlos syndromes and hypermobility spectrum disorders: An online survey.

Authors:  Jennifer E Glayzer; Barbara L McFarlin; Marco Castori; Marie L Suarez; Monya C Meinel; William H Kobak; Alana D Steffen; Judith M Schlaeger
Journal:  Am J Med Genet C Semin Med Genet       Date:  2021-11-07       Impact factor: 3.359

5.  Female sexual dysfunction in multiple system atrophy: a prospective cohort study.

Authors:  Cecilia Raccagni; Elisabetta Indelicato; Victoria Sidoroff; Martin Daniaux; Angelika Bader; Bettina Toth; Lukas A Jelisejevas; Margarethe Hochleitner; Alessandra Fanciulli; Fabian Leys; Sabine Eschlboeck; Christine Kaindlstorfer; Sylvia Boesch; Gregor K Wenning
Journal:  Clin Auton Res       Date:  2021-09-07       Impact factor: 4.435

6.  Long Term Outcome of Surgical Treatment of Central Introital Dyspareunia.

Authors:  Gilbert Donders; Meri Nderlita; Viktor-Jan Vertessen; Jente Reumers
Journal:  J Clin Med       Date:  2022-04-07       Impact factor: 4.241

Review 7.  Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?

Authors:  D Edwards; N Panay
Journal:  Climacteric       Date:  2015-12-26       Impact factor: 3.005

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.